TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
基本信息
- 批准号:8615692
- 负责人:
- 金额:$ 42.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-15 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAlzheimer&aposs DiseaseAnti-Inflammatory AgentsAnti-inflammatoryApoptosisApoptoticBehavioralBiologicalBrainBrain InjuriesCell membraneCellsCessation of lifeChronicCircadian RhythmsCoupledDendritic CellsDevelopmentEmployee StrikesEventExcisionEyeFamilyFeedbackFunctional disorderGenesGeneticGlycocalyxHippocampus (Brain)HomeostasisHumanImageImmuneImmune responseImmune systemImmunologic SurveillanceImpairmentIn VitroInfectionInflammationInflammatoryInflammatory ResponseInheritedInjuryKnowledgeLabelLifeLigandsLiteratureMaintenanceMethodsMicrogliaModelingMolecularMolecular GeneticsMultiple SclerosisMusMutant Strains MiceMutateNerve DegenerationNervous System PhysiologyNeuraxisNeurodegenerative DisordersNeuronsNeurophysiology - biologic functionNeurotoxinsParkinson DiseasePathway interactionsPhagocytesPhagocytosisPhotoreceptorsPhysiologicalPlayProcessProductionProtein SProteinsPublic HealthReceptor Protein-Tyrosine KinasesReceptor SignalingRecoveryRegulationRoleSentinelSeriesSignal TransductionSpinal CordStimulusStressStructure of retinal pigment epitheliumSynapsesSystemTestingTestisThalamic structureTherapeutic InterventionTimeTissuesTransgenic MiceVariantVirus Diseasesadult neurogenesisalpha synucleinautism spectrum disorderbasecell typecentral nervous system injurycytokinedesigndisease phenotypehuman diseasein vivoindexinginhibitor/antagonistmacrophagemouse modelmutantneurodevelopmentneuroinflammationneuron lossnigrostriatal pathwaypostnatalpublic health relevancereceptorrelating to nervous systemresearch studyresponsesertoli celltwo-photon
项目摘要
PROJECT SUMMARY/ABSTRACT
Deficiencies in the control of central nervous system (CNS) inflammation precipitate or
exacerbate a plethora of debilitating human diseases, yet our understanding of the basic
mechanisms that regulate neuroinflammation is incomplete. Microglia, the distinctive
tissue macrophages of the brain and spinal cord, are key players in this process. These
sentinel cells display two activities that are fundamental to the maintenance of neural
homeostasis - (i) immune surveillance and (ii) the phagocytosis of apoptotic cells (ACs)
and membranes. Studies of macrophages outside of the CNS have demonstrated that
both of these activities are strictly controlled by signaling through TAM receptor tyrosine
kinases. Although TAM receptors are also prominently expressed by microglia, the
importance of TAM signaling to microglial activation and function in the CNS is -
remarkably - unknown. The experiments of this proposal address this question. In Aim 1,
genetic and cell biological methods that rely on TAM receptor and ligand mouse mutants
will be used to assess the importance of TAM signaling in the homeostatic, non-
inflammatory phagocytosis of ACs that occurs continuously in the healthy mammalian
brain. In Aim 2, similar methods, coupled with confocal and two-photon imaging of
microglia in vivo, will be used to determine the role of TAM signaling in the localized
phagocytosis that underlies synaptic pruning and the remodeling of neuronal
connections in postnatal neural development. In Aim 3, a series of pro- and anti-
inflammatory challenges will be applied to TAM receptor- and ligand-deficient mice to
determine if inhibition of the innate inflammatory response in microglia is under TAM
control, as it is in cells of the immune system. Finally, in Aim 4, the knowledge gained
from the earlier aims will be applied to investigate the role that TAM regulation plays in
neurodegeneration, as assessed in both acute and progressive mouse models of
Parkinson's disease. Together, these studies will delineate the basic molecular, cellular,
and physiological features of a fundamentally new pathway of immune homeostasis in
the CNS, and potentially identify TAM receptors and ligands as new targets for
therapeutic intervention in neuroinflammatory and neurodegenerative disease.
项目概要/摘要
中枢神经系统 (CNS) 炎症控制缺陷会导致或
加剧了许多使人类衰弱的疾病,但我们对基本疾病的了解
调节神经炎症的机制并不完整。小胶质细胞,独特的
大脑和脊髓的组织巨噬细胞是这一过程的关键参与者。这些
前哨细胞表现出两种对于维持神经系统至关重要的活动
体内平衡 - (i) 免疫监视和 (ii) 凋亡细胞 (AC) 的吞噬作用
和膜。对中枢神经系统以外的巨噬细胞的研究表明
这两种活性均受到 TAM 受体酪氨酸信号传导的严格控制
激酶。尽管小胶质细胞也显着表达 TAM 受体,
TAM 信号传导对中枢神经系统小胶质细胞激活和功能的重要性是 -
值得注意的是——未知。该提案的实验解决了这个问题。在目标 1 中,
依赖于 TAM 受体和配体小鼠突变体的遗传和细胞生物学方法
将用于评估 TAM 信号在稳态、非
健康哺乳动物中持续发生的 AC 炎症吞噬作用
脑。在目标 2 中,类似的方法,加上共焦和双光子成像
体内小胶质细胞,将用于确定 TAM 信号在局部细胞中的作用
吞噬作用是突触修剪和神经元重塑的基础
产后神经发育的联系。在目标 3 中,一系列支持和反对的
炎症挑战将应用于 TAM 受体和配体缺陷的小鼠
确定小胶质细胞先天炎症反应的抑制是否受到 TAM 的影响
控制,就像在免疫系统细胞中一样。最后,在目标 4 中,获得的知识
早期目标中的内容将用于研究 TAM 监管在
神经变性,在急性和进行性小鼠模型中进行评估
帕金森病。这些研究将共同描述基本的分子、细胞、
免疫稳态的全新途径和生理特征
CNS,并有可能将 TAM 受体和配体确定为新靶点
神经炎症和神经退行性疾病的治疗干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Greg E Lemke其他文献
Greg E Lemke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Greg E Lemke', 18)}}的其他基金
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
8856378 - 财政年份:2013
- 资助金额:
$ 42.44万 - 项目类别:
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
9103238 - 财政年份:2013
- 资助金额:
$ 42.44万 - 项目类别:
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
9278310 - 财政年份:2013
- 资助金额:
$ 42.44万 - 项目类别:
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
8732718 - 财政年份:2013
- 资助金额:
$ 42.44万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 42.44万 - 项目类别:
Impact of TBI and Cognitive Decline on Alzheimer's Disease Brain-Derived Exosome Cargo
TBI 和认知能力下降对阿尔茨海默病脑源性外泌体货物的影响
- 批准号:
10662883 - 财政年份:2023
- 资助金额:
$ 42.44万 - 项目类别:
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10844877 - 财政年份:2023
- 资助金额:
$ 42.44万 - 项目类别:
Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias
用于治疗阿尔茨海默病和相关痴呆症的天然产物化合物的新组合
- 批准号:
10603708 - 财政年份:2023
- 资助金额:
$ 42.44万 - 项目类别:
Integrative Data Science Approach to Advance Care Coordination of ADRD by Primary Care Providers
综合数据科学方法促进初级保健提供者对 ADRD 的护理协调
- 批准号:
10722568 - 财政年份:2023
- 资助金额:
$ 42.44万 - 项目类别: